Fluticasone furoate / vilanterol (Relvar Ellipta)

BNF:: 3.2
Status:: Grey - after consultant/specialist recommendation
Decision Date:: June 2017

Traffic Lights Clinical Guidelines JAPC Other guidelines Further resources